Citation Formats
The role of SLC6A2 polimorphisms on response and resistance to atomoxetine treatment inattention deficit hyperactivity disorder
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

M. K. GÜL Et Al. , "The role of SLC6A2 polimorphisms on response and resistance to atomoxetine treatment inattention deficit hyperactivity disorder," 29. ulusal çocuk ve ergen ruh sağlığı ve hastalıkları kongresi , Turkey, 2019

GÜL, M. K. Et Al. 2019. The role of SLC6A2 polimorphisms on response and resistance to atomoxetine treatment inattention deficit hyperactivity disorder. 29. ulusal çocuk ve ergen ruh sağlığı ve hastalıkları kongresi , (Turkey).

GÜL, M. K., DEMİRCİ, E., ŞENER, E. F., & ÖNAL, M. G., (2019). The role of SLC6A2 polimorphisms on response and resistance to atomoxetine treatment inattention deficit hyperactivity disorder . 29. ulusal çocuk ve ergen ruh sağlığı ve hastalıkları kongresi, Turkey

GÜL, MELİKE Et Al. "The role of SLC6A2 polimorphisms on response and resistance to atomoxetine treatment inattention deficit hyperactivity disorder," 29. ulusal çocuk ve ergen ruh sağlığı ve hastalıkları kongresi, Turkey, 2019

GÜL, MELİKE K. Et Al. "The role of SLC6A2 polimorphisms on response and resistance to atomoxetine treatment inattention deficit hyperactivity disorder." 29. ulusal çocuk ve ergen ruh sağlığı ve hastalıkları kongresi , Turkey, 2019

GÜL, M. K. Et Al. (2019) . "The role of SLC6A2 polimorphisms on response and resistance to atomoxetine treatment inattention deficit hyperactivity disorder." 29. ulusal çocuk ve ergen ruh sağlığı ve hastalıkları kongresi , Turkey.

@conferencepaper{conferencepaper, author={MELİKE KEVSER GÜL Et Al. }, title={The role of SLC6A2 polimorphisms on response and resistance to atomoxetine treatment inattention deficit hyperactivity disorder}, congress name={29. ulusal çocuk ve ergen ruh sağlığı ve hastalıkları kongresi}, city={}, country={Turkey}, year={2019}}